Research Article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER Positive Breast Cancer Cells
Abstract:
Graphical Abstract:
Introduction:
Breast cancer (BC) is the most commonly diagnosed cancer worldwide, accounting for .% of total cases in both sexes. HER-positive BC is characterised by overexpression of the HER or ERBB protein, a tyrosine kinase receptor belonging to the epidermal growth factor (EGF) tyrosine kinase family. This subgroup accounts for approximately –% of all BC, and overexpression of HER is mainly due to amplification of the genomic locus, leading to a remarkable increase in the receptor at the cell surface. This facilitates…
Read more